Clinical Cancer Drugs


Giulio Francia
The University of Texas
El Paso, TX


Submit Manuscript
Submit Proposal

Open Access Articles

Evaluation of Fibrolytic Effect of Bauhinia purpurea L. open Access plus

Volume: 6  
Pp: 1-12
Jeevan Ranjan Dash, Tapas Kumar Sar*, Rinku Buragohain, Indranil Samanta and Rahul Nanotkar

Targeting Breast Cancer Stem Cells (BCSCs) with Liposomal Formulations open Access plus

Volume: 6  
Pp: 1-5
Sumayah Al-Mahmood*

Novel Molecular Targets and Mechanisms Involved in the Invasion and Metastasis of Pancreatic Cancer open Access plus

Volume: 6  
Pp: 1-13
Ziyi Li, Weidong Li, Yuqi Dong and Xueying Sun*

A Marine-based Meriolin (3-Pyrimidinylazaindole) Derivative (4ab) Targets PI3K/AKT /mTOR Pathway Inducing Cell Cycle Arrest and Apoptosis in Molt-4 Cells open Access plus

Volume: 6  
Pp: 1-8
Gousia Chashoo*, Umed Singh, Parvinder Pal Singh, Dilip M. Mondhe and Ram A. Vishwakarma

Computational Analysis of the Binding Site(s) of TNF β-TNFR1 Complex: Implications for Designing Novel Anticancer Agents open Access plus

Volume: 5   Issue: 2
Pp: 94-104
Trupti Kashinath Khatal and Ganesh Ulhasrao Chaturbhuj*

Erlotinib in Non-Small Cell Lung Cancer: From a thought to Necessity open Access plus

Volume: 5   Issue: 2
Pp: 87-93
Parijat Pandey and Harish Dureja*

May Endocrine Therapy be Associated with Cognitive Impairment in Breast Cancer Patients? open Access plus

Volume: 5   Issue: 2
Pp: 75-86
Riccardo Presciuttini, Romano Danesi and Guido Bocci*

New Robotic Technologies in Cancer Colon Screening open Access plus

Volume: 5   Issue: 2
Pp: 68-74
Luigi Manfredi* and Gianfranco Natale

Effects of Lysozyme on Ehrlich Ascites Carcinoma Cells: The Possible Physiological Role of Lysozyme in the Prevention of Carcinogenesis open Access plus

Volume: 5   Issue: 2
Pp: 113-118
Vardan K. Gasparyan*, Hayk A. Harutyunyan, Mariam V. Mikaelyan and Gayane G. Poghosyan

Formulation and Evaluation of pH Sensitive Sustained Release Hydrogel of Methotrexate open Access plus

Volume: 5   Issue: 2
Pp: 105-112
Swatantra Kumar Singh Kushwaha*, Prashant Kumar and Awani Kumar Rai

Novel Antibody Therapeutics Targeting Mesothelin In Solid Tumors open Access plus

Volume: 3   Issue: 2
Pp: 76-86
Xiao-Yan Zhao, Babu Subramanyam, Nenad Sarapa, Sven Golfier and Harald Dinter

Transforming Mutations of Jak3 (A573V and M511I) Show Differential Sensitivity to Selective Jak3 Inhibitors open Access plus

Volume: 3   Issue: 2
Pp: 131-137
G. Steven Martinez, Jeremy A. Ross and Robert A. Kirken

A Single Center Phase II Study of Continuous Infusion of Low-dose 5- fluorouracil for Heavily Pretreated Patients With Metastatic Colorectal Cancer open Access plus

Volume: 2   Issue: 2
Pp: 87-90
Hong-tao Chen, Yi-feng Liao, Mei Xiao, Lin Ma and Hong-Yu Zhang

The Importance of Lamivudine Therapy in Liver Cirrhosis Patients Related HBV with Advanced Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy open Access plus

Volume: 2   Issue: 2
Pp: 112-118
Koichi Momiyama, Hidenari Nagai, Yu Ogino, Takanori Mukouzu, Daigo Matsui, Michio Kogame, Teppei Matsui, Noritaka Wakui, Mie Shinohara, Yoshinori Igarashi and Yasukiyo Sumino

Emerging Role and Targeting of Carcinoembryonic Antigen-related Cell Adhesion Molecule 6 (CEACAM6) in Human Malignancies open Access plus

Volume: 2   Issue: 2
Pp: 100-111
Benny Johnson and Daruka Mahadevan

Preclinical Models to Study Breast Cancer open Access plus

Volume: 1   Issue: 2
Pp: 90-99
Cynthia M. Rodriguez, Paloma Valenzuela, Natzidielly Lerma and Giulio Francia

Impaired Autophagy Mediates Resistance to Low-Dose Metronomic Cyclophosphamide Chemotherapy open Access plus

Volume: 1   Issue: 2
Pp: 116-126
Annabelle Chow, Giulio Francia, Andrew Kouri, Christina Lee, John M. Ebos, Robert S. Kerbel and Urban Emmenegger